ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells

Autor: Makoto Ohashi, Nicholas P. Pauly, Kathleen R. Makielski, Shannon C. Kenney, Paul F. Lambert, Sai Wah Tsao, Denis Lee, Nicholas Van Sciver, Dhananjay M. Nawandar, Eric Johannsen, Jillian A. Bristol
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Keratinocytes
Epstein-Barr Virus Infections
Herpesvirus 4
Human

Cellular differentiation
Gene Expression
medicine.disease_cause
Biochemistry
Epithelium
Animal Cells
hemic and lymphatic diseases
Medicine and Health Sciences
Biology (General)
Epithelial cell differentiation
Nasopharyngeal Carcinoma
Cell Differentiation
Small interfering RNA
Virus Latency
Nucleic acids
medicine.anatomical_structure
Lytic cycle
Oncology
KLF4
Host-Pathogen Interactions
Cellular Types
Anatomy
Research Article
QH301-705.5
Immunology
Biology
Transfection
Research and Analysis Methods
Microbiology
Immediate-Early Proteins
Tubulins
Virology
DNA-binding proteins
medicine
Genetics
Humans
Gene Regulation
Molecular Biology Techniques
Non-coding RNA
Molecular Biology
B cell
Tumor Suppressor Proteins
Carcinoma
Biology and Life Sciences
Proteins
Cancers and Neoplasms
Epithelial Cells
Nasopharyngeal Neoplasms
Cell Biology
RC581-607
medicine.disease
Epstein–Barr virus
Viral Replication
BZLF1
Regulatory Proteins
Cytoskeletal Proteins
Biological Tissue
Nasopharyngeal carcinoma
Cancer research
RNA
Parasitology
Virus Activation
Immunologic diseases. Allergy
Developmental Biology
Transcription Factors
Zdroj: PLoS Pathogens, Vol 17, Iss 11 (2021)
PLoS Pathogens
PLoS Pathogens, Vol 17, Iss 11, p e1010045 (2021)
ISSN: 1553-7374
1553-7366
Popis: Epstein-Barr virus (EBV) is a human herpesvirus that causes infectious mononucleosis and contributes to both B-cell and epithelial-cell malignancies. EBV-infected epithelial cell tumors, including nasopharyngeal carcinoma (NPC), are largely composed of latently infected cells, but the mechanism(s) maintaining viral latency are poorly understood. Expression of the EBV BZLF1 (Z) and BRLF1 (R) encoded immediate-early (IE) proteins induces lytic infection, and these IE proteins activate each other’s promoters. ΔNp63α (a p53 family member) is required for proliferation and survival of basal epithelial cells and is over-expressed in NPC tumors. Here we show that ΔNp63α promotes EBV latency by inhibiting activation of the BZLF1 IE promoter (Zp). Furthermore, we find that another p63 gene splice variant, TAp63α, which is expressed in some Burkitt and diffuse large B cell lymphomas, also represses EBV lytic reactivation. We demonstrate that ΔNp63α inhibits the Z promoter indirectly by preventing the ability of other transcription factors, including the viral IE R protein and the cellular KLF4 protein, to activate Zp. Mechanistically, we show that ΔNp63α promotes viral latency in undifferentiated epithelial cells both by enhancing expression of a known Zp repressor protein, c-myc, and by decreasing cellular p38 kinase activity. Furthermore, we find that the ability of cis-platinum chemotherapy to degrade ΔNp63α contributes to the lytic-inducing effect of this agent in EBV-infected epithelial cells. Together these findings demonstrate that the loss of ΔNp63α expression, in conjunction with enhanced expression of differentiation-dependent transcription factors such as BLIMP1 and KLF4, induces lytic EBV reactivation during normal epithelial cell differentiation. Conversely, expression of ΔNp63α in undifferentiated nasopharyngeal carcinoma cells and TAp63α in Burkitt lymphoma promotes EBV latency in these malignancies.
Author summary Epstein-Barr virus (EBV) is an important cause of both epithelial cell and B cell human cancers. EBV-infected tumors have predominantly latent viral infection, allowing them to escape the cell killing that occurs during lytic viral infection. EBV is highly lytic in normal differentiated oral epithelial cells. Thus, an important question is how the virus maintains the latent form of viral infection in EBV-associated epithelial cell tumors such as undifferentiated nasopharyngeal carcinoma (NPC). This study demonstrates that the cellular transcription factor ΔNp63ɑ, which is specifically expressed in undifferentiated basal epithelial cells and is over-expressed in NPC tumors, maintains EBV latency by inhibiting the activity of the viral immediate-early (IE) promoter (Zp) that drives expression of the BZLF1 IE protein. A related splice variant, TAp63α, found in some EBV+ lymphomas, has a similar inhibitory effect. Our findings reveal that ΔNp63ɑ and TAp63α contribute to EBV latency in both epithelial and B cell tumors. Furthermore, since differentiation results in loss of ΔNp63ɑ expression, our results help to explain why lytic EBV reactivation is promoted by epithelial cell differentiation.
Databáze: OpenAIRE